SINGLE CENTRE, OPEN-LABEL & NON RANDOMIZED CLINICAL TRIAL TESTING LMWH EFFICACY ON PERINATAL OUTCOME INLATE SECOND TRIMESTER OLIGOHYDRAMNIOS CASES

SINGLE CENTRE, OPEN-LABEL & NON RANDOMIZED CLINICAL TRIAL TESTING LMWH EFFICACY ON PERINATAL OUTCOME INLATE SECOND TRIMESTER OLIGOHYDRAMNIOS CASES

Objective: To find out low molecular weight heparin (LMWH) efficacy inlate second trimester oligohydramnios cases. Study Design: Quasi-experimental study. Place and Duration of Study: Combined Military Hospital Malir, from Jan to Jun 2017. Methodology: A total of 30 patients having amniotic fluid in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pakistan Armed Forces medical journal 2021-06, Vol.71 (3), p.955-59
Hauptverfasser: Iftikhar, Bushra, Shahid, Aysha, Akram, Nuzhat Aisha, Afsheen, Afeera, Mushtaq, Rabia, Ehsan, Ambreen
Format: Artikel
Sprache:eng
Schlagworte:
Amniotic fluid
Anticoagulants
Apgar score
Birth weight
Births
Cesarean section
clinical trial
Clinical trials
Drug dosages
Health aspects
Hypertension
low molecular weight heparin
Molecular weight
Obstetrics
oligohydramnios
Osteoporosis
Patients
Pregnancy
Thrombocytopenia
Thrombosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective: To find out low molecular weight heparin (LMWH) efficacy inlate second trimester oligohydramnios cases. Study Design: Quasi-experimental study. Place and Duration of Study: Combined Military Hospital Malir, from Jan to Jun 2017. Methodology: A total of 30 patients having amniotic fluid index (AFI)
ISSN:0030-9648
2411-8842
DOI:10.51253/pafmj.v71i3.4992